Neko Health Secures $700M, Adds Big-Name Backers Ahead of NY Debut

The Spotify co-founder’s health startup, which offers a 60-minute preventive body scan, is taking a shot at MRI-based rivals Prenuvo and Ezra’s U.S. turf

Neko Health has closed a $700 million Series C round as the body-scanning startup prepares to open its first U.S. clinic in New York later this year, its first move outside the U.K. and Sweden since launch.

The round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with participation from existing backers Atomico, General Catalyst and Lakestar. New investors Liberty City Ventures, Positive Sum and BDT & MSD also joined. David Ofer of O.G. Venture Partners will join Neko’s board.

The raise follows a $260 million Series B in January 2025 and brings a lineup of celebrity and executive backers, including Mark Zuckerberg and Priscilla Chan, Tim Ferriss, Claudia Schiffer and Sir Matthew Vaughn, Ari Emanuel, Danny Meyer, Jimmy Iovine, Maria Sharapova, Thierry Henry and will.i.am. 

Existing investors Alexis Ohanian, Gary Vaynerchuk, Steven Bartlett, Katie Haun and Zoë Saldaña also participated.

Founded by Spotify CEO Daniel Ek and Hjalmar Nilsonne in 2023, Neko Health operates a proprietary in-clinic scan that measures skin, cardiovascular and metabolic markers in about 60 minutes without radiation. Results are reviewed on-site with a clinician. 

The scan costs £299 in the U.K. and 2,750 SEK in Sweden.

Neko has built its hardware and software in-house rather than licensing outside tech, which Nilsonne has pointed to as central to how fast the startup can iterate. Last month, the company opened a Stockholm clinic built around a new generation of its scanning devices, Derma-2, Echo-2 and Spectrum-2, which Neko said increases the volume and precision of data captured. The hardware is expected to roll out across all clinics in the coming months. 

More recently, Neko added clinician review of wearable data and body composition measurement to its scan.

“This funding is a strong vote of confidence in what we set out to do when we opened our
first clinic three years ago: a completely new healthcare experience designed to keep people
healthy, catch problems early and help prevent disease before it even starts,” Nilsonne said. “With this round, we’re taking that mission to the US for the first time, while continuing to invest in the research and technology that make prevention possible at scale.”

Demand is there, according to the company. Neko’s waitlist and registrations now top 350,000, with more than 100,000 scans completed so far across its UK and Sweden clinics. 

On outcomes, Neko said three in four returning members who had previously been flagged with severe or life-threatening conditions are now in good health or have the condition under control. 

Neko enters an already active field of preventive-screening players, though its approach differs from other imaging companies, as its scan isn’t an MRI.

Prenuvo, the whole-body MRI provider that has built a following among celebrities including Kate Hudson and Maria Menounos, raised $120 million last year and has since struck distribution deals, including a partnership with telehealth platform Hone Health. Function Health, known for its slate of more than 160 annual lab tests, acquired imaging startup Ezra last year and offers a 22-minute full-body MRI.